1. TNFα antagonist in combination with PD-1 blocker to prevent or retard malignant transformation of B[a]P-induced chronic lung inflammation. (1st March 2022) Authors: Zhao, Ai; Li, Fanfan; Wei, Cheng; Zhou, Zhujun; Luo, Xianqiang; Wu, Haiming; Ning, Chunhong; Liu, Wanyu; Li, Dong; Lin, Danni; Liu, Shuwen; Zhang, Guangji; Gao, Jimin Journal: Carcinogenesis Issue: Volume 43:Number 5(2022) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗